Enter Note Done
Go to previous page in this tab
Session
  • Presentation | Poster - [In-Person Posters Tues] Drug Development: Human
  • Poster
  • ASPIRE-FTD Study Update: A Phase 1/2 Study To Evaluate AVB-101 In FTD With GRN Mutations [Board No. Tuesday-0018]
  • Board no. Tuesday-0018
    Set Timezone

Gabriela Klodowska1, Joseph C. Masdeu2, Belen Pascual2, Marcin Ratajczak3, Maciej Czarnecki4, Richard Ryan Darby5, Alexander G. Murley6, Jonathan D Rohrer7, James B. Rowe6, Miroslaw Zabek8, Bradley Elder9, William Gray10, Chris M. Powell11, Jane YC Chan11, Yi-Ge Huang11, David L. Cooper11.
1Neuro-Care Centrum Medyczne, Katowice, Poland, 2Houston Neurological Institute and Weill Cornell Medicine, Houston Methodist, Houston, TX, USA, 3EuroMedis, Szczecin, Poland, 4Neuroprotect, Warsaw, Poland, 5Vanderbilt University Medical Center, Nashville, TN, USA, 6Cambridge University, Cambridge, United Kingdom, 7University College London, London, United Kingdom, 8Interventional Neurotherapies Center, Mazowiecki Szpital Bródnowski, Warsaw, Poland, 9Ohio State University Gene Therapy Institute, Columbus, OH, USA, 10Advanced Neurotherapies Centre, Cardiff University, Cardiff, United Kingdom, 11AviadoBio Ltd, London, United Kingdom.
Types
Main Session